AR088568A1 - Proceso mejorado para preparar un compuesto intermedio del inhibidor macrociclico de la proteasa tmc 435 - Google Patents

Proceso mejorado para preparar un compuesto intermedio del inhibidor macrociclico de la proteasa tmc 435

Info

Publication number
AR088568A1
AR088568A1 ARP120104040A ARP120104040A AR088568A1 AR 088568 A1 AR088568 A1 AR 088568A1 AR P120104040 A ARP120104040 A AR P120104040A AR P120104040 A ARP120104040 A AR P120104040A AR 088568 A1 AR088568 A1 AR 088568A1
Authority
AR
Argentina
Prior art keywords
compound
formula
tmc
alkyl
prepare
Prior art date
Application number
ARP120104040A
Other languages
English (en)
Spanish (es)
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47221505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR088568(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of AR088568A1 publication Critical patent/AR088568A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ARP120104040A 2011-10-28 2012-10-26 Proceso mejorado para preparar un compuesto intermedio del inhibidor macrociclico de la proteasa tmc 435 AR088568A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11187025 2011-10-28

Publications (1)

Publication Number Publication Date
AR088568A1 true AR088568A1 (es) 2014-06-18

Family

ID=47221505

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104040A AR088568A1 (es) 2011-10-28 2012-10-26 Proceso mejorado para preparar un compuesto intermedio del inhibidor macrociclico de la proteasa tmc 435

Country Status (17)

Country Link
US (2) US8981082B2 (enExample)
EP (1) EP2771339B1 (enExample)
JP (1) JP6231482B2 (enExample)
KR (1) KR20140086967A (enExample)
CN (1) CN104053658B (enExample)
AR (1) AR088568A1 (enExample)
AU (1) AU2012327934B2 (enExample)
BR (1) BR112014009849A2 (enExample)
CA (1) CA2848377A1 (enExample)
CL (1) CL2014001043A1 (enExample)
EA (1) EA201490892A1 (enExample)
ES (1) ES2671732T3 (enExample)
HK (1) HK1202120A1 (enExample)
IL (1) IL231892A (enExample)
MX (1) MX347650B (enExample)
TW (1) TWI574960B (enExample)
WO (1) WO2013061285A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41812A (fr) 2015-03-27 2018-01-30 Janssen Pharmaceuticals Inc Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc
WO2017064680A1 (en) * 2015-10-16 2017-04-20 Lupin Limited An improved process for the preparation of simeprevir sodium and intermediate thereof
CN109846883A (zh) * 2017-11-30 2019-06-07 常州寅盛药业有限公司 苯并呋喃衍生物与tmc435联合用药物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060008877A (ko) 2003-04-10 2006-01-27 베링거 인겔하임 인터내셔날 게엠베하 루테늄 착물 촉매 존재하의 복분해 반응에 의한거대사이클릭 화합물의 제조방법
PE20070211A1 (es) * 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
PL1934243T3 (pl) * 2005-09-09 2011-10-31 Boehringer Ingelheim Int Proces metatezy z zamknięciem pierścienia w zastosowaniu do wytwarzania peptydów makrocyklicznych
EP2224920A4 (en) 2007-12-06 2012-05-09 Enanta Pharm Inc PROCESS FOR THE PREPARATION OF MACROCYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS
WO2010015545A1 (en) * 2008-08-07 2010-02-11 F. Hoffmann-La Roche Ag Process for the preparation of a macrocycle
WO2010072742A1 (en) 2008-12-23 2010-07-01 Ortho-Mcneil-Janssen Pharmaceuticals, Inc Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv

Also Published As

Publication number Publication date
HK1202120A1 (en) 2015-09-18
ES2671732T3 (es) 2018-06-08
AU2012327934B2 (en) 2017-06-01
CN104053658A (zh) 2014-09-17
BR112014009849A2 (pt) 2016-07-05
US8981082B2 (en) 2015-03-17
TWI574960B (zh) 2017-03-21
JP2014530901A (ja) 2014-11-20
US20150152098A1 (en) 2015-06-04
WO2013061285A1 (en) 2013-05-02
EP2771339B1 (en) 2018-04-18
AU2012327934A1 (en) 2014-03-20
US9328108B2 (en) 2016-05-03
US20140235852A1 (en) 2014-08-21
JP6231482B2 (ja) 2017-11-15
CN104053658B (zh) 2018-03-13
EA201490892A1 (ru) 2014-08-29
EP2771339A1 (en) 2014-09-03
IL231892A (en) 2017-09-28
MX347650B (es) 2017-05-05
KR20140086967A (ko) 2014-07-08
TW201323423A (zh) 2013-06-16
IL231892A0 (en) 2014-05-28
CL2014001043A1 (es) 2014-07-25
CA2848377A1 (en) 2013-05-02
MX2014005070A (es) 2014-08-22

Similar Documents

Publication Publication Date Title
AR087791A1 (es) Derivados de benzofurano con sustitucion heterociclica y metodos para el uso de los mismos en el tratamiento de enfermedades virales
AR080433A1 (es) Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen.
SG163613A1 (en) Macrocyclic inhibitors of hepatitis c virus
AR068051A1 (es) Compuestos moduladores de la pi3k quinasa,composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento del cancer.
AR112774A1 (es) Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona
CO6150159A2 (es) Compuestos de heteroarilo utiles como inhibidores de enzimas de activacion e1
CO6180506A2 (es) Inhibidores de la proteasa ns3 del hcv
NZ599133A (en) Hcv protease inhibitors
CO6220931A2 (es) Inhibidores de serina proteasas para el tratamiento de infecciones de vhc
AR078540A1 (es) Compuestos heterociclicos utiles como inhibidores de pdk1
AR085327A1 (es) Inhibidores del virus de la hepatitis c
CO6561783A2 (es) Inhibidores del virus flaviviridae
PE20121479A1 (es) Inhibidores del virus de la hepatitis c
AR075368A1 (es) Inhibidores de glicosilceramida sintasa
CO6640266A2 (es) Proceso para preparar derivados de dihidropirrol
AR116537A1 (es) Método para preparar compuestos de uracilo que contienen isoxazolina mediante metilación
MX381182B (es) Compuesto heterociclico biciclico o triciclico novedoso.
CO2018010787A2 (es) Compuesto de griseofulvina
AR088246A1 (es) Derivados de etinilo
AR088568A1 (es) Proceso mejorado para preparar un compuesto intermedio del inhibidor macrociclico de la proteasa tmc 435
AR105774A1 (es) Procedimiento para la preparación de (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi-2,8-dimetilo-1,4-dihidro-1,6-naftiridina-3-carboxamida y su purificación para su uso como principio activo farmacéutico
UY34274A (es) Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv).
MX2017014858A (es) Proceso para preparar una dicetona macrociclica.
PE20191488A1 (es) Activador de nrf2
ES2571043T3 (es) Preparación de dihidropiridinas

Legal Events

Date Code Title Description
FB Suspension of granting procedure